Nine Masts Capital »

Outlook Therapeutics shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 233k 0.21

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Outlook Therapeutics

Schonfeld Strategic Advisors
Vanguard Capital Management
Vanguard Group
Sio Capital Management
Citadel Advisors
Susquehanna International
Gilpin Wealth Management
BlackRock
Commonwealth Equity Services
Geode Capital Management
Marshall Wace
Warberg Asset Management
Nine Masts Capital
Connective Capital Management
Vanguard Fiduciary Trust

View all funds holding Outlook Therapeutics